Generics

Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines.   Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. This will continue to be the case going forward, but the nature of the off-patent landscape will evolve […]

By Dr Natalia Dadivanyan, Segment Marketing Manager, Malvern Panalytical  Small molecules can face big challenges  Despite the emergence of, and excitement around, advanced therapeutic modalities, traditional small molecule pharmaceuticals still occupy a significant and steadily growing share of the market. A recent report indicated the current market size to be ~$166 billion, and a 5% compound […]

As the world’s largest generic producer how far advanced is India’s drug discovery push and where does it stand on the global stage? Lu Rahman explores. India has become a key player in the global pharmaceutical sector. The value of its part in this industry is expected to reach $120 billion by 2030. Its list […]